These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 318920)

  • 61. Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis.
    Murai T; Mori Y; Tatematsu K; Koide A; Hagiwara A; Makino S; Mori S; Wanibuchi H; Fukushima S
    Cancer Sci; 2005 Oct; 96(10):637-44. PubMed ID: 16232194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mutagenicity of alkyl-(omega-hydroxyalkyl) nitrosamines related to dibutylnitrosamine.
    Olajos EJ; Maverakis N; Cornish HH
    Mutat Res; 1978 Jan; 56(3):219-23. PubMed ID: 342939
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of urinary crystals induced by acetazolamide, uracil, and diethylene glycol on urinary bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated rats.
    Masui T; Shirai T; Imaida K; Uwagawa S; Fukushima S
    Toxicol Lett; 1988 Feb; 40(2):119-26. PubMed ID: 3341053
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutagenicity of nitrosamines formed from nitrosation of spermidine.
    Hotchkiss JH; Scanlan RA; Lijinsky W; Andrews AW
    Mutat Res; 1979 Nov; 68(3):195-9. PubMed ID: 390392
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Vascular changes during rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Tatematsu M; Cohen SM; Fukushima S; Shinohara Y; Ito N
    Gan; 1977 Feb; 68(1):127-8. PubMed ID: 863173
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of butylated hydroxyanisole added in vitro or administered to rats on N,N-dibutylnitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine metabolism by post-mitochondrial supernatant of liver homogenates.
    Pastorelli R; Ancidei A; Benfenati E; Fanelli R; Airoldi L
    Toxicology; 1988 Jan; 48(1):71-80. PubMed ID: 3336884
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Commentary on "tissue-specific mutagenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine as the basis for urothelial cell carcinogenesis." He Z, Kosinska W, Zhao ZL, Wu XR, Guttenplan JB, Department of Basic Science, New York University Dental College, NY, USA.: Mutat Res 2012;742(1-2):92-5 [Epub 2011 Dec 4].
    Scherr DS
    Urol Oncol; 2014 Feb; 32(2):214. PubMed ID: 24445298
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mutagenic and DNA-damaging effects of N-alkyl-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1979 Oct; 70(5):663-70. PubMed ID: 118074
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Focal suppression and induction of hyperplasia by the bladder carcinogens butyl(4-hydroxybutyl)nitrosamine and buty(3-carboxypropyl)nitrosamine in organ-cultured rat bladder epithelium.
    Reese DH; Friedman RD; Gaffield W; Keefer LK
    J Natl Cancer Inst; 1978 Jan; 60(1):219-23. PubMed ID: 628018
    [TBL] [Abstract][Full Text] [Related]  

  • 70. N-nitroso-butyl-3-carboxypropyl-amine (BCPN), a urinary bladder carcinogen, non-mutagenic in S. typhimurium.
    Pool BL; Gottfried-Anacker J; Eisenbrand G; Janzowski C
    Mutat Res; 1988; 209(1-2):79-83. PubMed ID: 3050508
    [No Abstract]   [Full Text] [Related]  

  • 71. Syntheses of N-alkyl-N-(omega-carboxyalkyl)nitrosamines related to N-butyl-N-(3-carboxypropyl)nitrosamine, principal urinary metabolite of a potent bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okada M; Suzuki E; Iiyoshi M
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3909-13. PubMed ID: 747858
    [No Abstract]   [Full Text] [Related]  

  • 72. Metallothionein modulates the carcinogenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine in mice.
    Kondo Y; Himeno S; Endo W; Mita M; Suzuki Y; Nemoto K; Akimoto M; Lazo JS; Imura N
    Carcinogenesis; 1999 Aug; 20(8):1625-7. PubMed ID: 10426817
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metabolic fate of n-methyl-N-dodecylnitrosamine in the rat, in relation to its carcinogenicity to the urinary bladder.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1981 Oct; 72(5):713-6. PubMed ID: 7327371
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Gut microbiome and bladder cancer: A new link through nitrosamine metabolism.
    Mani S
    Cell Host Microbe; 2024 Oct; 32(10):1637-1639. PubMed ID: 39389023
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of disulfiram on the carcinogenicity of N-butyl-N-(3-carboxypropyl)nitrosamine in the rat.
    Irving CC; Daniel DS; Murphy WM
    Carcinogenesis; 1983; 4(5):617-20. PubMed ID: 6850994
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutagenic and DNA-damaging effects of N-(omega-acetoxyalkyl and omega-methoxycarbonylalkyl)-N-(alpha-acetoxyalkyl)nitrosamines, models for metabolically activated N,N-dialkylnitrosamines with an omega-functional group.
    Mochizuki M; Suzuki E; Anjo T; Wakabayashi Y; Okada M
    Gan; 1980 Feb; 71(1):124-30. PubMed ID: 6769736
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Scanning electron microscopy of changes in the urinary bladder in dogs treated with N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
    Hirao Y; Sasaki K; Sanma S; Ozono S; Babaya K; Okajima E
    Urol Res; 1987; 15(1):25-9. PubMed ID: 3824711
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutagenicity of beta-oxidized N,N,-di-n-propylnitrosamine derivatives in S. typhimurium mediated by rat and hamster tissues.
    Camus A; Bertram B; Krüger FW; Malaveille C; Bartsch H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):293-302. PubMed ID: 136104
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High susceptibility of an analbuminemic congenic strain of rats with an F344 genetic background to induced bladder cancer and its possible mechanism.
    Takahashi M; Shumiya S; Maekawa A; Hayashi Y; Nagase S
    Jpn J Cancer Res; 1988 Jun; 79(6):705-9. PubMed ID: 3137197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.